Morgan Stanley’s SAB Biotherapeutics, Inc. Warrant SABSW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.88K | Hold |
146,439
| – | – | ﹤0.01% | 7038 |
|
|
2025
Q1 | $3.81K | Hold |
146,439
| – | – | ﹤0.01% | 7053 |
|
|
2024
Q4 | $11K | Hold |
146,439
| – | – | ﹤0.01% | 6766 |
|
|
2024
Q3 | $5.27K | Hold |
146,439
| – | – | ﹤0.01% | 6905 |
|
|
2024
Q2 | $6.94K | Sell |
146,439
-2,500
| -2% | -$118 | ﹤0.01% | 6774 |
|
|
2024
Q1 | $4.47K | Sell |
148,939
-148,939
| -50% | -$4.47K | ﹤0.01% | 6919 |
|
|
2023
Q4 | $9K | Buy |
297,878
+148,939
| +100% | +$4.5K | ﹤0.01% | 6856 |
|
|
2023
Q3 | $10.4K | Hold |
148,939
| – | – | ﹤0.01% | 6723 |
|
|
2023
Q2 | $15.5K | Hold |
148,939
| – | – | ﹤0.01% | 6644 |
|
|
2023
Q1 | $5.36K | Hold |
148,939
| – | – | ﹤0.01% | 7034 |
|
|
2022
Q4 | $7K | Hold |
148,939
| – | – | ﹤0.01% | 7057 |
|
|
2022
Q3 | $9K | Hold |
148,939
| – | – | ﹤0.01% | 7118 |
|
|
2022
Q2 | $22K | Sell |
148,939
-1,907
| -1% | -$282 | ﹤0.01% | 6939 |
|
|
2022
Q1 | $72K | Buy |
150,846
+119,439
| +380% | +$57K | ﹤0.01% | 6508 |
|
|
2021
Q4 | $56K | Buy |
+31,407
| New | +$56K | ﹤0.01% | 6757 |
|